Difference between revisions of "Team:Bulgaria/MEDALSILVER"

 
(3 intermediate revisions by the same user not shown)
Line 262: Line 262:
 
p{
 
p{
 
text-align: center !important;
 
text-align: center !important;
margin-left: 128px;
+
margin-left: 64px;
margin-right: 128px;
+
margin-right: 64px;
 
font-family: 'Montserrat', sans-serif !important;
 
font-family: 'Montserrat', sans-serif !important;
 
font-size: 20px !important;
 
font-size: 20px !important;
Line 547: Line 547:
 
<div class="contentHolder" id="MEDALSILVER">
 
<div class="contentHolder" id="MEDALSILVER">
 
<h1>Collaborations</h1>
 
<h1>Collaborations</h1>
 +
<div style="font-family: 'Wallpoet', sans-serif; font-size: 20px;">✔</div>
 
<p>
 
<p>
Our most meaningful collaboration by far is with Team Athens. Exchanging vital project ideas with them proved really helpful for both sides in the end. We lent a helping hand in their InterLab study by sending them our Measurement Kit, because we didn’t participate in it and they did. The best of all are the lasting friendships we made!
+
Our most meaningful collaboration by far is with Team Athens. Exchanging vital project ideas with them proved really helpful for both sides in the end. We lent a helping hand in their InterLab study by sending them our Measurement Kit, because we didn’t participate in it and they did. The best of all are the lasting friendships we made!<br>
https://2018.igem.org/Team:Athens/Collaborations
+
 
 +
<a id="downlaodlink" href="https://2018.igem.org/Team:Athens/Collaborations">LINK TO Team: Athens</a>
 +
 
 +
 
 
</p>
 
</p>
 
</div>
 
</div>
Line 557: Line 561:
 
<div class="contentHolder" id="MEDALSILVER">
 
<div class="contentHolder" id="MEDALSILVER">
 
<h1>Human Practices</h1>
 
<h1>Human Practices</h1>
 +
<div style="font-family: 'Wallpoet', sans-serif; font-size: 20px;">✔</div>
 
<p>
 
<p>
Our project idea was inspired mostly by a donation campaign for a colleague of ours, organised in our faculty. We dived head-first into this problem and uncovered that the average survival rates for Bulgarian patients with cystic fibrosis are far lower than those for patients living in more developed countries. One of the main reasons behind that contrast is untimely diagnosis. This served as a huge push for us to try and develop our system and, in a way, try to give a second chance to patients by providing timely diagnosis. We presented the problem and our solution at various different science-oriented events - Sofia Science Festival 2018, for instance. We also organized our own campaign, The 65 SynBio Roses, in which we had people draw and/or color roses, some of which - with iGEM chromoproteins. This way, we managed to introduce people not only to an important issue in need of a solution, but to synthetic biology’s problem-solving potential, too.  
+
Our project idea was inspired mostly by a donation campaign for a colleague of ours, organised in our faculty. We dived head-first into this problem and uncovered that the average survival rates for Bulgarian patients with cystic fibrosis are far lower than those for patients living in more developed countries. One of the main reasons behind that contrast is untimely diagnosis. This served as a huge push for us to try and develop our system and, in a way, try to give a second chance to patients by providing timely diagnosis. We presented the problem and our solution at various different science-oriented events - Sofia Science Festival 2018, for instance. We also organized our own campaign, The 65 SynBio Roses, in which we had people draw and/or color roses, some of which - with iGEM chromoproteins. This way, we managed to introduce people not only to an important issue in need of a solution, but to synthetic biology’s problem-solving potential, too. <br>
 +
<a id="downlaodlink" href="https://2018.igem.org/Team:Bulgaria/publicEng">LINK TO PUBLIC ENGAGEMENTS</a>
 +
 
 
</p>
 
</p>
 
</div>
 
</div>
Line 626: Line 633:
 
       <a href="https://2018.igem.org/Team:Bulgaria/MEDALSILVER" id="activeMenu">SILVER</a>
 
       <a href="https://2018.igem.org/Team:Bulgaria/MEDALSILVER" id="activeMenu">SILVER</a>
 
  <a href="https://2018.igem.org/Team:Bulgaria/MEDALGOLD">GOLD</a>
 
  <a href="https://2018.igem.org/Team:Bulgaria/MEDALGOLD">GOLD</a>
 +
<a href="https://2018.igem.org/Team:Bulgaria/MEDALAWARD">SPECIAL AWARD</a>
 
</div>
 
</div>
 
   </div>  
 
   </div>  

Latest revision as of 23:32, 17 October 2018

Validated part

LINK TO BBa_K2847000

Collaborations

Our most meaningful collaboration by far is with Team Athens. Exchanging vital project ideas with them proved really helpful for both sides in the end. We lent a helping hand in their InterLab study by sending them our Measurement Kit, because we didn’t participate in it and they did. The best of all are the lasting friendships we made!
LINK TO Team: Athens

Human Practices

Our project idea was inspired mostly by a donation campaign for a colleague of ours, organised in our faculty. We dived head-first into this problem and uncovered that the average survival rates for Bulgarian patients with cystic fibrosis are far lower than those for patients living in more developed countries. One of the main reasons behind that contrast is untimely diagnosis. This served as a huge push for us to try and develop our system and, in a way, try to give a second chance to patients by providing timely diagnosis. We presented the problem and our solution at various different science-oriented events - Sofia Science Festival 2018, for instance. We also organized our own campaign, The 65 SynBio Roses, in which we had people draw and/or color roses, some of which - with iGEM chromoproteins. This way, we managed to introduce people not only to an important issue in need of a solution, but to synthetic biology’s problem-solving potential, too.
LINK TO PUBLIC ENGAGEMENTS